Risk factor | Score |
---|---|
Age > 65 yrs | 1 |
Structural lung disease (e.g. COPD) | 2 |
Previous antibiotic treatment | 2 |
Late onset (5 or more days after admission) | 3 |
Invasive or non-invasive mechanical ventilation on onset date | 3 |
Extrapulmonary organ failure | 4 |
1b. PEG therapeutic recommendations for HAP/VAP depending on the complicated pathogen risk score (CPRS) | |
Group I (CPRS = 1 or 2) | Aminopenicillin/BLI or cephalosporin 2/3a or quinolone 3/4 or carbapenem 2 |
Group II (CPRS = 3 to 5) | Acylaminopenicillin/BLI or cephalosporin 3b/4 or quinolone 2/3 or carbapenem 1 |
Group III (CPRS = 6 and more) | Cephalosporin 3b/4 or acylaminopenicilline/BLI or carbapenem 1 |
 | Always in combination with either Quinolone 2/3 or aminoglycoside* |